List of insiders holdings for ARENA PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Flynn James E DEERFIELD CAPITAL LP DEERFIELD MANAGEMENT CO DEERFIELD INTERNATIONAL LTD DEERFIELD PARTNERS LP 10% Owner | 2013-02-14 15:39:23 | 7,479,424 0 | 7,479,424 | Form 13G |
| LAMPERT MARK N Director 10% Owner | 2003-10-21 18:21:20 | 0 4,520,212 | 4,520,212 | Form 4 |
| LIEF JACK President and CEO | 2015-03-04 17:54:17 | 697,189 0 | 697,189 | Form 4 |
| BEHAN DOMINIC P EVP & Chief Scientific Officer | 2016-03-04 18:13:19 | 525,000 0 | 525,000 | Form 4 |
| CHALMERS DEREK T Former VP, Research and Dir. | 2004-06-14 21:45:13 | 370,667 0 | 370,667 | Form 4 |
| Bielasz Jennifer Kathleen VP, Finance and Accounting | 2016-03-04 18:20:10 | 252,000 0 | 252,000 | Form 4 |
| Audet Craig Michael SVP, Opn & Head Glob Reg Afrs | 2016-03-04 18:17:51 | 207,500 0 | 207,500 | Form 4 |
| SHANAHAN WILLIAM R JR SVP & Chief Medical Officer | 2016-03-04 18:16:01 | 207,500 0 | 207,500 | Form 4 |
| Mezzino Maurice James SVP, Corporate Development | 2016-03-04 18:18:55 | 175,000 0 | 175,000 | Form 4 |
| White Christine Anna Director | 2017-06-14 19:47:22 | 150,000 0 | 150,000 | Form 4 |
| SCHNEIDER PHILLIP M Director | 2017-06-14 19:46:25 | 150,000 0 | 150,000 | Form 4 |
| BICE SCOTT H Director | 2017-06-14 19:42:04 | 150,000 0 | 150,000 | Form 4 |
| AJIT-SIMH K A Sr. VP, Quality & Reg Compl | 2011-03-17 19:31:33 | 130,000 0 | 130,000 | Form 4 |
| BELCHER DONALD D Director | 2016-06-15 20:48:00 | 125,000 0 | 125,000 | Form 4 |
| HIXSON HARRY F JR Director | 2016-06-15 20:51:15 | 125,000 0 | 125,000 | Form 4 |
| Munshi Amit President and CEO | 2022-03-11 16:11:40 | 114,897 0 | 114,897 | Form 4 |
| HOFFMAN ROBERT SVP, Finance and CFO | 2014-12-17 19:47:13 | 103,074 0 | 103,074 | Form 4 |
| WILLIAMS JOYCE H Former VP, Drug Development | 2004-08-16 17:37:28 | 74,198 0 | 74,198 | Form 4 |
| BEELEY NIGEL R A Former VP, Chief Chem. Officer | 2004-06-09 19:49:35 | 70,907 0 | 70,907 | Form 4 |
| Klassen Preston EVP and CMO | 2020-03-03 18:15:19 | 70,000 0 | 70,000 | Form 4 |
| Lind Kevin Robert Executive VP and CFO | 2020-03-03 18:10:08 | 70,000 0 | 70,000 | Form 4 |
| Aurentz Vincent Executive VP and CBO | 2022-03-11 16:07:39 | 55,964 0 | 55,964 | Form 4 |
| Lisicki Robert EVP, Chief Commercial Officer | 2022-03-11 16:06:17 | 37,563 0 | 37,563 | Form 4 |
| Stelzer Laurie EVP & Chief Financial Officer | 2022-03-11 16:12:08 | 37,208 0 | 37,208 | Form 4 |
| Manion Douglas J. EVP Research & Development | 2022-03-11 16:12:30 | 36,462 0 | 36,462 | Form 4 |
| Schmidt Joan EVP, General Counsel & Sec | 2022-03-11 16:09:49 | 36,287 0 | 36,287 | Form 4 |
| LAFORCE JAMES Director | 2010-03-18 20:12:25 | 30,462 0 | 30,462 | Form 4 |
| MOONEY JOSEPH F Former Chief Financial Officer | 2004-01-05 20:23:49 | 27,785 0 | 27,785 | Form 4 |
| FRANK FREDERICK Advisory Director Director | 2004-01-21 19:09:15 | 25,000 0 | 25,000 | Form 4 |
| Nova Tina Susan Director | 2022-03-11 16:24:43 | 20,843 0 | 20,843 | Form 4 |
| SPECTOR STEVEN W EVP, General Counsel & Sec | 2020-02-28 18:02:34 | 17,437 0 | 17,437 | Form 4 |
| MAFFUID PAUL W VP, Pharmaceutical Development | 2004-07-02 18:56:26 | 16,604 0 | 16,604 | Form 4 |
| SCOTTI LOUIS J VP, Marketing and Business Dev | 2008-03-05 18:32:57 | 15,000 0 | 15,000 | Form 4 |
| WOODS RANDALL E Director | 2019-11-13 20:14:36 | 14,230 0 | 14,230 | Form 4 |
| GALLAHUE KIERAN Director | 2022-03-11 16:23:59 | 9283 3628 | 12,911 | Form 4 |
| Jarrett Jennifer Director | 2022-03-11 16:23:13 | 11,217 0 | 11,217 | Form 4 |
| NEIL GARRY ARTHUR Director | 2022-03-11 16:22:49 | 11,217 0 | 11,217 | Form 4 |
| LAVIGNE LOUIS J JR Director | 2006-08-01 19:51:23 | 10000 0 | 10000 | Form 4 |
| BRISTOW DUKE K Director | 2005-01-18 20:19:34 | 10000 0 | 10000 | Form 4 |
| TOMS ROBERT L Director | 2005-01-18 20:26:37 | 10000 0 | 10000 | Form 4 |
| FETZER OLIVER Director | 2022-03-11 16:24:23 | 9692 0 | 9692 | Form 4 |
| Dallas Jayson Donald Alexander Director | 2022-03-11 16:22:04 | 7152 0 | 7152 | Form 4 |
| Knobil Katharine Director | 2022-03-11 16:23:33 | 6821 0 | 6821 | Form 4 |
| Cabell Christopher EVP, Head of R&D, and CMO | 2020-11-30 16:01:24 | 6401 0 | 6401 | Form 4 |
| Soni Manmeet Singh Director | 2020-06-18 17:07:19 | 5902 0 | 5902 | Form 4 |
| Schoch Steven J Director | 2022-03-11 16:22:28 | 4600 0 | 4600 | Form 4 |
| Ouzren Nawal Director | 2022-03-11 16:21:42 | 4555 0 | 4555 | Form 4 |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC Indirect Beneficial Owner 10% Owner | 2004-08-05 13:40:19 | 0 0 | 0 | Form 13D |